Sri Lanka Clinical Trials Registry (SLCTR)

Registry Profile

General Information

Address:
Sri Lanka Medical Association
No 6, Wijerama Mawatha
Colombo 7
Sri Lanka

Registry URL: https://slctr.lk

Registration URL: https://slctr.lk
Email: srilankactr@gmail.com

Content

1. Does the Registry accept prospective registration of interventional clinical trials submitted by Responsible Registrants?
Yes

2. Is the Registry open to all prospective registrants (ICMJE), either internationally, or within one or more specific countries?
Yes

2.1. From which countries will the Registry accept trials for registration?
All countries

2.2. If the Registry is not open to ALL registrants (that is, accepts trials only from a particular sponsor, health care condition (eg cancer), intervention, etc) please specify which trials the Registry is open to.
Not applicable

3. Is the Registry able to collect and publicly display the WHO Trial Registration Data Set? (ICMJE)
Yes

4. Does the Registry endeavour to keep registered information up-to-date?
Yes

4.1. Does the Registry have a reminder system to facilitate the submission of updated information by the responsible registrant?
Yes

4.2. Does the Registry highlight or flag records that are not current (have not been updated in more than 12 months) so readers are aware that information contained in such records may not be current?
No, there is no mechanism to flag trials, but progress reports will indicate that reports have not been submitted. Can develop a mechanism to flag such trials if it is mandatory.

5. Does the Registry never remove a trial once it has been registered?
Yes

Quality and Validity

6. Does the Registry have a mechanism in place to ensure the validity of the registered data? (ICMJE)
Yes

6.1. Does the registry contact Responsible Registrants when one or more items in the Trial Registration Data Set are incomplete or potentially inaccurate?
Yes

6.2. Does the registry have documented Standard Operating Procedures (SOPs)?
Yes

6.3. Are mechanisms in place to ensure compliance with these SOPs (eg staff training)?
Yes

6.4. Please briefly describe these compliance mechanisms.
The Administrative Assistant is fully conversant with the procedures.

7. Does the registry maintain a publicly accessible audit trail so changes made to the WHO Trial Registration Data Set for an individual trial can be tracked?
Yes

8. It is desirable that Primary Registries participate in the development of the International Standards for Clinical Trial Registries. Does the Registry agree to participate in the development of these standards?
Yes

Accessibility

9. Is the WHO Trial Registration Data Set accessible to the public at no charge? (ICMJE)
Yes

10. Is the WHO Trial Registration Data Set electronically searchable? (ICMJE)
Yes

11. Is the WHO Trial Registration Data Set available in English?
Yes

12. Can registrants submit a trial for registration at any time of day on any day of the week (24 hours a day, seven days a week)?
Yes

13. Can the register be searched at any time of day on any day of the week (24 hours a day, seven days a week)?
Yes

14. It is desirable that the WHO Trial Registration Data Set be available in the language/s of the countries served by the registry. Please indicate the languages in which the registered information is displayed.
English

14.1. If trials are registered in more than one language, does the registry check the quality of translation?
Not applicable

15. What quality control measures does the registry have in place to make sure that all items in the WHO Trial Registration Data Set are as complete and accurate as possible?
All applications are cross checked by the Administrator before acceptance. Where the data is incomplete or inappropriate, applicants are contacted and asked to clarify or resubmit data. The SLCTR Committee discusses all applications at its regular meetings regarding accuracy and completeness of data.

Unambiguous Identification

16. Does the Registry have processes in place to prevent the registration of a single trial more than once on their register?
Yes

16.1. Please briefly describe these processes.
The Registry database is searched to trial duplicate registration.

17. Does the Registry agree to facilitate the retrospective linking (or bridging) on the WHO Search Portal of a single trial registered with more than one registry by encouraging Responsible Registrants to enter secondary identifiers, including the UTN?
Yes

18. Does the Registry agree, as part of the registration process, to search the WHO Search Portal to ascertain if the trial has already been registered on another WHO Primary Registry?
Yes

Technical Capacity

19. Does the Registry agree to submit the WHO Trial Registration Data Set for all records on their registry to the Central Repository?
Yes

19.1. Is the registry regularly submitting data to the ICTRP?
Yes

20. Does the Registry have access to a database that is used to store and manage the submitted data?
Yes

20.1. If not, please provide details of the database that will be used and where it is based.
Not applicable

21. Does the Registry have access to adequate information technology support?
No

22. Does the Registry have adequate security and other provisions against data corruption/loss?
Yes

Administration and Governance

23. Does the Registry have at least a national remit?
Yes

23.1. From which countries does the Registry have the remit to act as their Primary Registry?
Sri Lanka

24. Does the Registry have a letter of support from the relevant Ministry of Health or other agency?
Yes

24.1. Please specify the names of the government agencies that have given their support.
Ministry of Health, Sri Lanka

25. Does the Registry publicly disclose ownership, governance structure and not/for-profit status?
Yes

25.1. Please indicate the web address where this information is displayed.
http://www.slctr.lk

26. Is the Registry managed by a not-for-profit agency? (ICMJE)
Yes

27. Should the register cease to function, does the register agree that at least the WHO Trial Registration Data Set for all trial records will be transferred to a WHO Primary Register?
Yes

27.1. Does the registry agree to inform the WHO ICTRP Secretariat of changes that may be relevant to its status as a WHO Primary Registry?
Yes

28. It is desirable that Primary Registries have a strategy in place addressing the medium to long term sustainability of the registry. Does the Registry have such a strategy in place?
Yes

29. Other Governance information:

29.1. What is the name of the agency (or agencies) that fund the registry?
Sri Lanka Medical Association

29.2. What is the name of the agency that manages the registry?
Sri Lanka Clinical Trials Registry Committee (which is nominated by the Sri Lanka Medical Association)

29.3. Is the agency that manages the registry a for-profit agency?
No

29.4. If the agency is for-profit, is the data on the register (database) also available on a Registry that is managed by a not-for-profit agency?
Not applicable

29.5. If the answer to 29.4 is "yes", then please specify the name of the additional Registry.
Not applicable

29.6. Please describe any other ownership or governance issues of relevance to the register. (eg Does the register have an Advisory Board. If so, what is its role?

Adhesion to WHO Trial Registration Data Set